<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03208374</url>
  </required_header>
  <id_info>
    <org_study_id>17-327</org_study_id>
    <nct_id>NCT03208374</nct_id>
  </id_info>
  <brief_title>Feasibility Information for Timely Completion of Neuroimaging Data Collection</brief_title>
  <official_title>Feasibility Information for Timely Completion of Neuroimaging Data Collection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will recruit approximately 5,000 patients with histologically confirmed cancer who
      have successfully completed MSK-IMPACT panel testing and collect information about tumor
      genetic results and patient exercise behavior history.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 27, 2017</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterize exercise participant behavior history via exercise survey</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Participants who have undergone MSK-IMPACT panel testing will complete the exercise history survey. The 10 minute survey only asks participants about their exercise history, both in period before their most recent diagnosis as well as their current exercise behavior.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Cancer</condition>
  <condition>Carcinoma</condition>
  <arm_group>
    <arm_group_label>MSK-IMPACT genetic panel testing</arm_group_label>
    <description>Participants have completed MSK-IMPACT genetic panel testing on Memorial Sloan Kettering Cancer Center protocol IRB #12-245 in the last 2 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prior Exercise Behavior Questions - Harvard Health Professionals Exercise Questionnaire</intervention_name>
    <description>Participants will be asked how often on average over the past year they participated in walking or hiking; jogging; running; calisthenics, aerobics, rowing, Nordic track; bicycling; tennis, squash, racquetball; lap swimming; weightlifting; and other aerobic exercise (e.g. heavy outdoor work), as well as their usual walking pace and flights of stairs climbed daily over the past 12 months prior to diagnosis.</description>
    <arm_group_label>MSK-IMPACT genetic panel testing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Current Exercise Behavior Questions: International Physical Activity Questionnaire Short Form (IPAQ SF)</intervention_name>
    <description>The purpose of this questionnaire is to provide common instruments that can be used to obtain internationally comparable data on exercise exposure in adults aged 15 to 80 years old.</description>
    <arm_group_label>MSK-IMPACT genetic panel testing</arm_group_label>
    <other_name>IPAQ SF</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study cohort will consist of approximately 5,000 participants with histology confirmed
        cancer who have successfully completed MSK-IMPACT panel testing and are being treated at
        any Memorial Sloan Kettering Cancer Center site.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically-confirmed cancer.

          -  IMPACT testing with completed genomic profile completed within the last three years

          -  Registered to Memorial Sloan Kettering Cancer Center protocol IRB# 12-245 and/or IRB
             #06-107

          -  Received primary oncology care at Memorial Sloan Kettering Cancer Center

          -  Access to an email address

          -  &gt;/= 18 years of age

          -  ECOG Performance Status of 0 or 1

          -  My MSK: Patient Portal user* (*only required if patient chooses to provide wearable
             device-enabled capture of exercise data)

        Exclusion Criteria:

          -  Unable to speak and read English

          -  Not willing to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jones Lee, MD</last_name>
    <phone>646-888-8136</phone>
    <email>jonesl3@mskcc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Basking Ridge</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jones Lee, MD</last_name>
      <phone>646-888-8136</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Monmouth</name>
      <address>
        <city>Middletown</city>
        <state>New Jersey</state>
        <zip>07748</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jones Lee, MD</last_name>
      <phone>646-888-8136</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center @ Suffolk</name>
      <address>
        <city>Commack</city>
        <state>New York</state>
        <zip>11725</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jones Lee, MD</last_name>
      <phone>646-888-8136</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Westchester</name>
      <address>
        <city>Harrison</city>
        <state>New York</state>
        <zip>10604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jones Lee, MD</last_name>
      <phone>646-888-8136</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering @ Rockville</name>
      <address>
        <city>Rockville Centre</city>
        <state>New York</state>
        <zip>11570</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jones Lee, MD</last_name>
      <phone>646-888-8136</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://mskcc.org</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Histologically confirmed cancer</keyword>
  <keyword>IMPACT testing</keyword>
  <keyword>17-327</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

